Condition
Frontotemporal Dementia (FTD) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Frontotemporal Dementia (FTD) clinical trials that are recruiting, at sites in 4 countries (most in Italy (3), United States (1), Canada (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 4Countries
Newest Frontotemporal Dementia (FTD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Automated language analysis to help diagnose neurodegenerative diseases | — | Bari | Recruiting | Oct 30, 2026 |
| Beta-frequency brain stimulation for frontotemporal dementia | — | Brescia, BS | Recruiting | Apr 1, 2026 |
| Using a new PET tracer to measure TDP-43 protein in dementia and ALS | Early Phase 1 | Amsterdam | Recruiting | Mar 24, 2025 |
| Identifying protein biomarkers in biofluids for neurodegenerative disorders | — | Pozzilli, Italy | Recruiting | Jan 31, 2025 |
| Using vortioxetine to improve mood and cognition in patients with frontotemporal dementia | Phase 2 | Baltimore, Maryland | Recruiting | Sep 19, 2024 |
| Comprehensive assessment of neurodegeneration and dementia | — | Calgary, Alberta and 18 other locations | Recruiting | Jan 18, 2018 |
All recruiting trials (6)
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Beta-frequency brain stimulation for frontotemporal dementia
This trial will try a single session of beta-frequency transcranial alternating current stimulation (tACS) to see if it is safe and can improve brain rhythms and symptoms in people over 40 with frontotemporal dementia.
-
Using a new PET tracer to measure TDP-43 protein in dementia and ALS
This study is testing a new imaging method to see if it can safely detect a specific protein linked to frontotemporal dementia and ALS in the brains of people with these conditions and healthy volunteers.
-
Identifying protein biomarkers in biofluids for neurodegenerative disorders
This study is trying to find specific proteins in blood and other fluids that could help doctors diagnose and manage neurodegenerative diseases like Parkinson's and Alzheimer's earlier and better.
-
Using vortioxetine to improve mood and cognition in patients with frontotemporal dementia
This study is testing if a medication called vortioxetine can help improve mood and thinking skills in people with early-stage behavioral variant Frontotemporal Dementia.
-
Comprehensive assessment of neurodegeneration and dementia
This project will collect brain scans, cognitive tests, and biological samples over time to see how dementia and related conditions progress in adults aged 50–90, including people with Parkinson's and people without cognitive problems.
Related topics
Quick answers
How many Frontotemporal Dementia (FTD) clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (3 trials), United States (1 trial), Canada (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.